Peptide G
Alternative Names: Antagonist G; PTL 68001; PTL 68300BLatest Information Update: 30 May 2007
At a glance
- Originator Cancer Research Technology
- Class Antineoplastics
- Mechanism of Action Substance P inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Colorectal cancer; Pancreatic cancer; Small cell lung cancer